POA
BMY icon

Pergamon Offshore Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Pergamon Offshore Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,145
Closed -$342K – 168
2015
Q2 		$342K Buy
+5,145
New +$339K 0.36% 107

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pergamon Offshore Advisors's BMY Position: Q3 2015 in Review

Pergamon Offshore Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2015, closing a stake of 5,145 shares — an estimated $342K sold.

Pergamon Offshore Advisors first reported a position in BMY in Q2 2015 and held it in 1 quarter. The position peaked at $342K in Q2 2015. 1,454 funds tracked by Wall St. Rank hold BMY as of Q3 2015.

  • Pergamon Offshore Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2015 after selling out during the quarter.
  • Pergamon Offshore Advisors sold 5,145 Bristol-Myers Squibb shares in Q3 2015, an estimated $342K.
  • Pergamon Offshore Advisors first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 1 quarter.
  • Pergamon Offshore Advisors's Bristol-Myers Squibb position peaked at $342K in Q2 2015.
  • 1,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.

Based on Pergamon Offshore Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.